Table: Cyfuse Biomedical -2025 parent results

Cyfuse Biomedical KK

13/02/2026 06:01

Feb 13 (Reuters)- 
          Cyfuse Biomedical K.K. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended        Year to         NEXT   
              Dec 31, 2025     Dec 31, 2024     Dec 31, 2026      YEAR     
                 LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS         RESULTS          FORECAST     H1 FORECAST 
  Sales          230 mln          54 mln          278 mln                  
              (+324.3 pct)     (-10.9 pct)      (+20.4 pct)                
  Operating   loss 828 mln     loss 896 mln      loss 1.08                 
  Recurring   loss 761 mln     loss 869 mln      loss 1.06                 
  Net         loss 763 mln     loss 872 mln      loss 1.06                 
  EPS        loss 86.78 yen  loss 108.34 yen  loss 110.22 yen              
  Ann Div          NIL             NIL              NIL                    
  -Q2 Div          NIL             NIL              NIL                    
  -Q4 Div          NIL             NIL              NIL                    
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T